Kiyoshi Migita
Overview
Explore the profile of Kiyoshi Migita including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
347
Citations
3177
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fukui S, Sumiyoshi R, Koga T, Hosogaya N, Narita S, Morimoto S, et al.
Cureus
. 2025 Feb;
17(2):e78974.
PMID: 39958406
Background Idiopathic multicentric Castleman disease (iMCD) is a chronic inflammatory condition for which Janus kinase (JAK) inhibition has been hypothesized to be a potential treatment. However, filgotinib, a JAK1 preferential...
2.
Fukui S, Sumiyoshi R, Koga T, Hosogaya N, Narita S, Morimoto S, et al.
Cureus
. 2025 Feb;
17(2):e78865.
PMID: 39944226
Background Idiopathic multicentric Castleman disease (iMCD) is a chronic systemic inflammatory disease characterized by the production of interleukin (IL)-6. The contribution of Janus kinase, downstream of IL-6 signaling, to the...
3.
Asano T, Yoshida S, Matsuoka N, Ishikawa M, Sato A, Ogawa S, et al.
Medicine (Baltimore)
. 2024 Dec;
103(51):e40994.
PMID: 39705455
Rationale: Takayasu arteritis (TAK) is an autoimmune disease that causes chronic inflammation targeting the aortic wall. Since many patients are resistant to steroid treatment, multiple immunosuppressants or interleukin-6 (IL-6) suppression...
4.
Temmoku J, Yoshida S, Tsuchihashi K, Sumichika Y, Saito K, Matsumoto H, et al.
Fukushima J Med Sci
. 2024 Dec;
71(1):63-68.
PMID: 39647862
Myositis-specific autoantibodies play an important role on the disease phenotype of idiopathic inflammatory myopathies (IIMs). Anti-signal recognition particle (SRP) antibody-positive patients with IIMs may present with severe myopathy and highly...
5.
Oka S, Higuchi T, Furukawa H, Shimada K, Okamoto A, Fujimori M, et al.
Biomark Insights
. 2024 Dec;
19:11772719241297171.
PMID: 39640205
Background: Rheumatoid arthritis (RA) is complicated with interstitial lung disease (ILD). Gastroesophageal reflux disease is prevented by infection and is a predisposing factor for idiopathic pulmonary fibrosis. However, the prevalence...
6.
Suzuki E, Matsumoto H, Yoshida S, Saito K, Asano T, Odajima H, et al.
Intern Med
. 2024 Nov;
PMID: 39603630
It is difficult to distinguish idiopathic multicentric Castleman disease (iMCD) from immunoglobulin G4-related disease (IgG4-RD). A 47-year-old man was diagnosed with venous thrombosis in the right lower extremity. Multiple lymphadenopathies...
7.
Oka S, Higuchi T, Furukawa H, Shimada K, Okamoto A, Fujimori M, et al.
J Clin Med
. 2024 Nov;
13(22).
PMID: 39597905
A common complication in patients with rheumatoid arthritis (RA) is interstitial lung disease (ILD). Antibodies (Abs) to anti-aminoacyl-transfer ribonucleic acid synthetase (ARS) are linked to ILD in patients with idiopathic...
8.
Fujita Y, Ogawa S, Sumichika Y, Saito K, Yoshida S, Matsumoto H, et al.
Intern Med
. 2024 Oct;
PMID: 39462592
Familial Mediterranean fever (FMF) is the most prevalent hereditary autoinflammatory disease and is caused by the MEFV gene. In patients carrying MEFV exon 10 variants, FMF usually develops at an...
9.
Yoshida S, Fujita Y, Koga T, Matsumoto H, Sumichika Y, Saito K, et al.
Immunol Med
. 2024 Oct;
48(1):58-69.
PMID: 39376199
This study aimed to identify biomarkers to distinguish adult-onset Still's disease (AOSD) and to predict disease phenotypes. In total, 49 patients diagnosed with AOSD and 200 patients with common diseases...
10.
Matsumoto H, Sudo R, Fujita Y, Onizawa M, Saito K, Sumichika Y, et al.
BMC Immunol
. 2024 Oct;
25(1):63.
PMID: 39354368
Objectives: Carcinoembryonic-antigen-related cell-adhesion molecule 1 (CEACAM1) is an adhesion molecule that acts as a coinhibitory receptor in the immune system. We previously demonstrated that CEACAM1 is predominantly expressed on peripheral...